COMBRETASTATIN A4, TRANS-
UNII ND4BUQ9WHL

Substance Identification & Data

This profile provides standardized clinical and technical data for Combretastatin A4, Trans-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ND4BUQ9WHL.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 117048-62-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ND4BUQ9WHL

CAS Registry Number

117048-62-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

COMBRETASTATIN A4, TRANS-

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H20O5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

HVXBOLULGPECHP-AATRIKPKSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

5386397

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O(C)c1c(OC)cc(/C=C/c2cc(O)c(OC)cc2)cc1OC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Combretastatin A4, Trans-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.